New hope for tough prostate cancer: experimental drug enters human testing

NCT ID NCT06609005

Summary

This study is testing a new drug called INV-9956 for men with advanced prostate cancer that has spread and is no longer responding to standard hormone therapies and chemotherapy. The first part aims to find a safe dose, and the second part will look for early signs that the drug can slow or shrink tumors. It is enrolling about 84 adult men who have already tried other treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Shanghai Cancer Center

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • He'nan Cancer Hospital

    RECRUITING

    Zhengzhou, He'Nan, 450000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Hoag Family Cancer Institute

    NOT_YET_RECRUITING

    Newport Beach, California, 92663, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Honor Health

    RECRUITING

    Scottsdale, Arizona, 85258, United States

    Contact Email: •••••@•••••

    Contact

  • Hu'nan Cancer Hospital

    NOT_YET_RECRUITING

    Changsha, Hu'Nan, 410006, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Liaoning Cancer Hospital

    RECRUITING

    Shenyang, Liaoning, 110801, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • NEXT Oncology

    RECRUITING

    Fairfax, Virginia, 22031, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Nanjing Drum Tower Hospital

    RECRUITING

    Nanjing, Jiangsu, 210008, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Next Oncology - Houston

    RECRUITING

    Houston, Texas, 77054, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shandong Cancer Hospital

    RECRUITING

    Ji'nan, Shandong, 250000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Summit Cancer Centers

    NOT_YET_RECRUITING

    Spokane, Washington, 99208, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Fujian Medical University

    NOT_YET_RECRUITING

    Fuzhou, Fujian, 350005, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • The First Affiliated Hospital, School of Medicine, Zhejiang University

    RECRUITING

    Hangzhou, Zhejiang, 310003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Tianjin Medical University Cancer Institute & Hospital

    RECRUITING

    Tianjin, Tianjin Municipality, 300202, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UC Irvine Medical Center

    RECRUITING

    Orange, California, 92868, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UT Health

    RECRUITING

    San Antonio, Texas, 78229, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Zhejiang Provincial People's Hospital

    NOT_YET_RECRUITING

    Hangzhou, Zhejiang, 310014, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.